]>
IRCT20200414047070N1 IRCT 2020-04-21 Fasa University of Medical Sciences Effect of ppd on recovery of covid disease 19 Determining the effect of skin test purified protein derivative (PPD) on the recovery process of patients with COVID 19 in patients with this disease 2020-05-04 anticipated 50 Complete https://irct.ir/trial/47169 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After registering the patient's personal details, including name and surname, gender, age, weight, place of residence, occupation, the presence of underlying diseases and disease profile, randomly assigned to one of the two groups tested and controlled based on AB and randomized block design. BA. 3 Covid 19. Intervention 1: Intervention group: People with covid 19 Patients after accidental registration of personal information including name and surname, gender, age, weight, place of residence, job, the presence of underlying diseases and disease profile in one of the two intervention groups and Control based on AB and BA random block design. In addition to treatment with the common drugs Chloroquine and Lopinavir / Ritonavir, the intervention group (PPd (purified protein derivative) is also performed for them in the intervention group. We evaluate and evaluate by an infectious disease specialist through daily tests for patients and CT Scan of the chest on days 0, 3 and 7, and Corona testing on days 7 and 14 for patients to relieve fever. Intervention 2: Control group: People with Covid 19 Patients after random registration of personal information including name and surname, gender, age, weight, place of residence, occupation, the presence of underlying diseases and disease profile randomly in one of the two groups tested And control based on AB and BA random block design. They are only routinely treated with chloroquine and Lopinavir / Ritonavir, and are evaluated by an infectious disease specialist through daily tests for patients and CT Scan of the chest on days 0, 3 and 7, and Corona testing on days 7 and 14 for patients, fever relief, face Accept. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Abdolah Azizi
Jomhore
Fasa Iran (Islamic Republic of) 7461837513 +98 71 5331 4200 hadiazizi2323@yahoo.com Fasa University of Medical Sciences scientific Dr.jalal karimi
Jomhori Aslami
fasa Iran (Islamic Republic of) 7461837513 +98 71 5335 9600 Jalalmd7@gmail.com Fasa University of Medical Sciences Iran (Islamic Republic of) Having covid 19 no limit no limit Both People with severe illness(. Spo2<60%2. Severe respiratory distress3. Heamodynamic instabilitty 4. Acid base disturbance 5. Severe Anemia) People with defective immune systems Liver disease U07.1 COVID-19, virus identified Treatment - Drugs Treatment - Drugs Intervention group: People with covid 19 Patients after accidental registration of personal information including name and surname, gender, age, weight, place of residence, job, the presence of underlying diseases and disease profile in one of the two intervention groups and Control based on AB and BA random block design. In addition to treatment with the common drugs Chloroquine and Lopinavir / Ritonavir, the intervention group (PPd (purified protein derivative) is also performed for them in the intervention group. We evaluate and evaluate by an infectious disease specialist through daily tests for patients and CT Scan of the chest on days 0, 3 and 7, and Corona testing on days 7 and 14 for patients to relieve fever Control group: People with Covid 19 Patients after random registration of personal information including name and surname, gender, age, weight, place of residence, occupation, the presence of underlying diseases and disease profile randomly in one of the two groups tested And control based on AB and BA random block design. They are only routinely treated with chloroquine and Lopinavir / Ritonavir, and are evaluated by an infectious disease specialist through daily tests for patients and CT Scan of the chest on days 0, 3 and 7, and Corona testing on days 7 and 14 for patients, fever relief, face Accept. Having covid 19. Timepoint: 3-7-14. Method of measurement: Negative test. Fasa University of Medical Sciences Approved 2020-04-18 Ethics committee of fasa University of Medical Sciences Daneshgah fasa Fars Iran (Islamic Republic of)